34 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... screen within 1 ... 0.5mL IM at 0, 1– ... #Treatment #management ... #HIVAIDS #pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
steroids to treat infectious ... jirovecii pneumonia, id ... Corticosteroids #Adjuvant #InfectiousDiseases ... #Infections #Pharmacology ... #Management #Treatment
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... in HIV-AIDS Preventing ... in Severely Ill ... #Treatment #management ... #HIVAIDS #pharmacology
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
Critically ill patients ... prophylaxis for primary prevention ... hospitalization) • Pathophysiology ... #criticalcare #pharmacology ... #management
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
define the type of infection ... Consult ID if needed ... ampicillin #management ... #infectiousdisease ... #antibiogram #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Perforation) Pathophysiology ... Epidemiology: • #1 ... immunocompromised, IBD ... 10 mg/kg IV x 1 ... #treatment #infectiousdiseases
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... opportunistic #infections ... #HIVAIDS #management ... #pharmacology # ... pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Epidemiology: • 1- ... Guillain-Barre Pathophysiology ... response preceding infection ... • Weakness: mild ... Syndrome #diagnosis #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
mg/kg on days 1– ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... in HIV-AIDS Preventing ... ) for 1–4 doses ... #Treatment #management ... #HIVAIDS #pharmacology